Angene Chemical
Draw
|
Currency :
Home Products

AG003U6O

599-79-1 | SULFASALAZINE

Chemical structure of SULFASALAZINE, CAS 599-79-1
AG003U6O
sdsSDS
sdsCOA

Price

$0.00

Add to Cart
WARNING This product is not for human or veterinary use.
Request For Quotation
CAS Number 599-79-1
Catalog Number AG003U6O(AGN-PC-0OD0D2)
Chemical Name SULFASALAZINE
EC Number 209-974-3
IUPAC Name 2-hydroxy-5-[[4-(pyridin-2-ylsulfamoyl)phenyl]diazenyl]benzoic acid
InChI InChI=1S/C18H14N4O5S/c23-16-9-6-13(11-15(16)18(24)25)21-20-12-4-7-14(8-5-12)28(26,27)22-17-3-1-2-10-19-17/h1-11,23H,(H,19,22)(H,24,25)
InChI Key NCEXYHBECQHGNR-UHFFFAOYSA-N
MDL Number MFCD00057363
Molecular Formula C18H14N4O5S
Molecular Weight 398.3926
SMILES S(=O)(=O)(Nc1ccccn1)c1ccc(cc1)/N=N/c1cc(C(=O)O)c(cc1)O
UNII 3XC8GUZ6CB
Synonyms
Asulfidine, Azulfadine, Azulfidine, Azulfidine EN, Colo Pleon, Colo-Pleon, Pleon, Pyralin EN, ratio Sulfasalazine, ratio-Sulfasalazine, Salazopyrin, Salazosulfapyridine, Salicylazosulfapyridine, Sulfasalazin Heyl, Sulfasalazin medac, Sulfasalazin-Heyl, Sulfasalazine, Sulfasalazine FNA, Sulphasalazine, Ucine, Ulcol, sulfasalazine, 599-79-1, Salicylazosulfapyridine, Azulfidine, Salazosulfapyridine, Sulphasalazine, Salazopyrin, Asulfidine, Salazopyridin, Accucol, Azopyrin, Sulcolon, Colo-Pleon, Salazopiridazin, Azopyrine, Benzosulfa, Reupirin, Salisulf, Salazosulfapyridin, Sulfasalazina, Sulfasalazinum, w-t Sasp oral, Sulfasalazin, Azulfidine EN, Sulfazalazine, Azulfidine EN-tabs, Salazosulfapiridina, Salazosulfapyridinum, Sas-500, Azosulfidin, SASP, Salazo-sulfapyridinum, 5-(p-(2-Pyridylsulfamyl)phenylazo)salicylic acid, S.A.S.-500, 5-(4-(2-Pyridylsulfamoyl)phenylazo)-2-hydroxybenzoic acid, 4-(Pyridyl-2-amidosulfonyl)-3'-carboxy-4'-hydroxyazobenzene, 5-((p-(2-Pyridylsulfamoyl)phenyl)azo)salicylic acid, Salazopyrin EN-Tabs, Sulfasalazinum [INN-Latin], 2-Hydroxy-5-((4-((2-pyridinylamino)sulfonyl)phenyl)azo)benzoic acid, Sulfasalazina [INN-Spanish], CHEBI:9334, NSC 203730, S.A.S. 500, Salazosulfapyridinum [INN-Latin], UNII-3XC8GUZ6CB, Salazosulfapiridina [INN-Spanish], SI-88, NSC 667219, CCRIS 4713, 5-[4-(2-Pyridylsulfamoyl)phenylazo]salicylic Acid, C18H14N4O5S, HSDB 3395, Benzoic acid, 2-Hydroxy-5-[[4-[(2-pyridinylamino)sulfonyl]phenyl]azo]-, EINECS 209-974-3, 3XC8GUZ6CB, Sulfasalazine (Azulfidine), BRN 0356241, Benzoic acid, 2-hydroxy-5-((4-((2-pyridinylamino)sulfonyl)phenyl)azo)-, S.A.S., 2-hydroxy-5-{[4-(pyridin-2-ylsulfamoyl)phenyl]diazenyl}benzoic acid, 5-[p-(2-Pyridylsulfamoyl)phenylazo]salicylic acid, (E)-2-hydroxy-5-((4-(N-(pyridin-2-yl)sulfamoyl)phenyl)diazenyl)benzoic acid, 2-HYDROXY-(5-([4-(2-PYRIDINYLAMINO)SULFONYL]PHENYL)AZO)BENZOIC ACID, 5-(p-(2-Pyridinylsulfamoyl)Phenylazo)Salicylic Acid, MFCD00057363, NSC203730, NSC667219, Salicylic acid, 5-((p-(2-pyridylsulfamoyl)phenyl)azo)-, SSZ, NCGC00090903-01, Azulfadine, CAS-599-79-1, DSSTox_CID_1256, 2-hydroxy-5-(2-{4-[(pyridin-2-yl)sulfamoyl]phenyl}diazen-1-yl)benzoic acid, 2-hydroxy-5-[(E)-{4-[(pyridin-2-ylamino)sulfonyl]phenyl}diazenyl]benzoic acid, DSSTox_RID_76043, 5-[p-(2-Pyridylsulfamyl)phenylazo]salicylic acid, DSSTox_GSID_21256, (3Z)-6-Oxo-3-[[4-(pyridin-2-ylsulfamoyl)phenyl]hydrazinylidene]cyclohexa-1,4-diene-1-carboxylic acid, Salicylic acid, 5-[[p-(2-pyridylsulfamoyl)phenyl]azo]-, 2-Hydroxy-5-[[4-[(2-pyridinylamino)sulfonyl]phenyl]azo]benzoic acid, Alti-Sulfasalazine, PMS-Sulfasalazine, Sulfasalazine [USAN:INN], Azulfidine (TN), SMR000059146, Azlufidine EN-Tabs, Sulphasalazine, N-, 13gs, 5-(p-(2-Pyridylsulfamoyl)phenylazo)salicylic acid, Pms-Sulfasalazine E.C., SR-05000001721, 5-[[p-(2-Pyridylsulfamoyl)phenyl]azo]salicylic acid, Sulfasalazine (USP/INN), S.A.S. Enteric-500, Iwata, 2-hydroxy-5-({4-[(2-pyridylamino)sulfonyl]phenyl}diazenyl)benzoic acid, Prestwick_848, Sulfasalazine [USAN:USP:INN:BAN], Salazopyrin en-tabs, AC1NTMDP, Spectrum_000998, AC1NS4RK, AC1NSE0P, Sulfasalazine(Azulfidine), Prestwick0_000520, Prestwick1_000520, Prestwick2_000520, Prestwick3_000520, Spectrum2_001216, Spectrum3_001364, Spectrum4_000347, Spectrum5_001443, CHEMBL421, Epitope ID:122672, AC1Q72VB, SCHEMBL4514, SCHEMBL4515, Salazosulfapyridine (JP17), SCHEMBL18490, BSPBio_000479, BSPBio_002888, KBioGR_000753, KBioGR_002314, KBioSS_001478, KBioSS_002316, 5-22-08-00433 (Beilstein Handbook Reference), MLS000759399, MLS001424109, MLS006011702, BIDD:GT0161, DivK1c_000860, SPECTRUM1500552, 5-(para-(2-pyridylsulfamoyl)phenylazo)salicylic acid, SPBio_001032, SPBio_002400, 5-[4-(2-Pyridylsulfamoyl)-phenylazo]-salicylic acid, BPBio1_000527, CHEMBL100848, CHEMBL242373, GTPL4840, SCHEMBL1079598, SCHEMBL1229516, CHEMBL1206016, DTXSID0021256, SCHEMBL10289061, CHEBI:94500, CTK8B4012, HMS502K22, KBio1_000860, KBio2_001478, KBio2_002314, KBio2_004046, KBio2_004882, KBio2_006614, KBio2_007450, KBio3_002108, KBio3_002794, cMAP_000018, NCEXYHBECQHGNR-QZQOTICOSA-N, NCEXYHBECQHGNR-UHFFFAOYSA-N, NINDS_000860, OQANPHBRHBJGNZ-BKUYFWCQSA-N, OQANPHBRHBJGNZ-UHFFFAOYSA-N, HMS1569H21, HMS1921C05, HMS2051J21, HMS2090P13, HMS2092K07, HMS2096H21, HMS2232H07, HMS3370D16, HMS3393J21, HMS3655G07, HMS3713H21, LS-46, Pharmakon1600-01500552, BCP13311, KS-00000H3J, ZINC3831490, Azulfidine;Salazopyrin;Sulphasalazine, Tox21_111037, Tox21_201239, Tox21_300541, ANW-43676, BDBM50097125, BDBM50103596, CCG-39145, DL-510, KM0360, NSC757330, s1576, SBB058178, ZINC14768602, ZINC85550135, 2-hydroxy-5-(4-[(pyridin-2-ylamino)sulfonyl]phenyl}diazenyl)benzoic acid, AKOS002311709, AKOS025116975, AKOS026749974, Tox21_111037_1, WLN: T6NJ BSWMR DNUNR DQ CVQ, ZINC100030102, ZINC100031653, AN-8097, CCG-100987, CS-2145, DB00795, HS-0062, MCULE-7533021815, NC00237, NSC-203730, NSC-667219, NSC-757330, VA11798, IDI1_000860, SMP2_000059, NCGC00016518-01, NCGC00090903-02, NCGC00090903-03, NCGC00090903-04, NCGC00090903-05, NCGC00090903-06, NCGC00090903-07, NCGC00090903-09, NCGC00090903-11, NCGC00186644-01, NCGC00254313-01, NCGC00258791-01, AC-20497, AK163126, CPD000059146, H881, HY-14655, SAM001246530, SC-45949, SMR004703430, SBI-0051526.P003, AB0013330, AB2000147, TL8003811, TR-020767, FT-0603483, S0580, ST50767935, SW196979-4, C07316, D00448, J10488, AB00052101-04, AB00052101-06, AB00052101_07, AB00052101_08, 599S791, I06-0676, Q-201769, SR-05000001721-1, SR-05000001721-2, SR-05000001721-3, Sulfasalazine, analytical standard, >=98% (HPLC), 5-[[4-(2-Pyridylsulfamoyl)phenyl]azo]salicylic acid, BRD-K10670311-001-06-4, BRD-K10670311-001-08-0, Sulphasalazine, Antibiotic for Culture Media Use Only, F2173-1125, Z2030502809, 4-(Pyridyl-2-amidosulfonyl)-3''-carboxy-4''-hydroxyazobenzene, Sulfasalazine, European Pharmacopoeia (EP) Reference Standard, 2-hydroxy-5-[(E)-[4-(2-pyridylsulfamoyl)phenyl]azo]benzoic acid, 2-Hydroxy-5-[4-(pyridin-2-ylsulfamoyl)-phenylazo]-benzoic acid, Sulfasalazine, United States Pharmacopeia (USP) Reference Standard, (E)-2-hydroxy-5-((4-(N-pyridin-2-ylsulfamoyl)phenyl)diazenyl)benzoic acid, 2-hydroxy-5-((4-(N-pyridin-2-ylsulfamoyl)phenyl)diazenyl)benzoic acid, 2-Hydroxy-5-((4-[(2-pyridinylamino)sulfonyl]phenyl)diazenyl)benzoic acid #, 2-hydroxy-5-{(E)-[4-(pyridin-2-ylsulfamoyl)phenyl]diazenyl}benzoic acid, 2-hydroxy-5-[(E)-2-{4-[(pyridin-2-yl)sulfamoyl]phenyl}diazen-1-yl]benzoic acid, 6-oxo-3-(2-[4-(n-pyridin-2-ylsulfamoyl)phenyl]hydrazono)cyclohexa-1,4-dienecarboxylic acid, (3E)-6-oxo-3-[[4-(2-pyridylsulfamoyl)phenyl]hydrazono]cyclohexa-1,4-diene-1-carboxylic acid, (3E)-6-oxo-3-[[4-(pyridin-2-ylsulfamoyl)phenyl]hydrazinylidene]cyclohexa-1,4-diene-1-carboxylic acid, (Z)-6-oxo-3-(2-(4-(N-(pyridin-2-yl)sulfamoyl)phenyl)hydrazono)cyclohexa-1,4-diene-1-carboxylic acid, 6-oxo-3-((4-(pyridin-2-ylsulfamoyl)phenyl) hydrazinylidene]cyclohexa-1,4-diene-1-carboxylic acid, 6-oxo-3-[[4-(pyridin-2-ylsulfamoyl)phenyl]hydrazinylidene]cyclohexa-1,4-diene-1-carboxylic acid, 737754-28-8, Rorasul, Pleon, Ucine, Ulcol, sulfasalizine, Colo Pleon, Salazopyrine, Sulfasalazin Heyl, Sulfasalazin-Heyl, Pyralin EN, Sulfasalazin medac, Sulfasalazine FNA, ratio Sulfasalazine, ratio-Sulfasalazine, Sulfasalazine-d4, EN, Azulfidine, Salazopyrin (TN), Sulfasalazine Pfizer Brand, D02ZTJ, D0GH2C, FNA Brand of Sulfasalazine, Heyl Brand of Sulfasalazine, Salazosulfapyridine (JP15), medac Brand of Sulfasalazine, Pfizer Brand of Sulfasalazine, Ratiopharm Brandof Sulfasalazine, Ashbourne Brand of Sulfasalazine, Alphapharm Brand of Sulfasalazine, C18-H14-N4-O5-S, Henning Berlin Brand of Sulfasalazine, Sulfasalazine (salicylazosulfapyridine), CID5353980, CID5359476, CID5384001, CS-T-42938, Sanofi Synthelabo Brand of Sulfasalazine, A5770, Sulfasalazine, 95%, Anti-inflammatory - 1G 1g, D012460, Benzoic acid, 2-hydroxy-5-[[4-[(2-pyridinylamino) sulfonyl]phenyl]azo]-, SAS, 1346606-50-5,

Related Research Chemicals

    CERTIFICATE OF ANALYSIS
    Chemical Name: Batch Number:
    Chemical Structure: CAS Registry No:
    		Product ID:
    Manufacture Date:
    Storage Temperature:
    Formula:
    Molecular Weight:
    Quantity:
    Analysis Data:
    Test: Result:
    Conclusion: The above product meets the specifications of Angene.
    Analyst:Chase
    Date:
    Reviewed by:Jessie
    Date:
    Angene International Limited